ADVB — Advanced Biomed Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1941029 ·
Last close
$2.10
Market Cap
$3.47M
52W High
$24.23
52W Low
$1.80
ADV30
66,396
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 127,637 | — | -4,829,689 | 694,999 | 13,750,716 | 385,535 | 1,473,989 |
| Mar 2026 | 0 | — | -519,836 | -488,942 | 10,646,324 | 2,602,697 | 1,436,587 |
| Dec 2025 | 0 | — | -396,642 | 6,857,921 | 10,850,712 | 2,604,666 | 1,369,070 |
| Sep 2025 | 0 | — | -523,914 | -386,901 | 6,242,970 | 2,656,519 | 3,238,846 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-961,341
Investing CF
$-2,581,850
Financing CF
$1,326,215
CapEx
$-18,156
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$4.07
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-12,555,967
Inventory
$8,835
Receivables
$13,361,977
ST Investments
—
EBIT TTM
$-6,353,500
Pretax Income TTM
$-6,390,703
Interest Exp TTM
$112
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$127,637
EBITDA
$-6,174,261
Free Cash Flow
$-12,022,238
Enterprise Value
$6,161,240
Total Cash
$385,535
Total Debt
$1,078,215
Shares Out
1,652,133
Trailing EPS
$-5.00
Book Value
$7.43
ROE
-79.5%
ROA
-21.3%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 127,637 | -6,141,042 | 6,677,077 | 13,750,716 | 1,473,989 | 12,276,727 | -1,946,943 |
| Jun 2025 | — | — | — | — | — | — | — |
| Jun 2024 | 0 | -2,541,572 | -2,782,278 | 4,460,247 | 2,796,989 | 1,663,258 | -2,126,340 |
| Jun 2023 | 0 | -3,071,223 | -3,732,777 | 4,599,977 | 3,294,389 | 1,305,588 | -2,963,625 |
| Jun 2022 | 0 | — | -4,027,722 | — | — | 3,491,596 | -741,450 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$10,646,324
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MGRX | MANGOCEUTICALS, INC. | $3.45M | $0.16 | — |
| ACON | Aclarion, Inc. | $3.95M | $1.37 | — |
| HLYK | HealthLynked Corp | $2.51M | $0.85 | — |
| BGLC | BioNexus Gene Lab Corp | $2.25M | $0.77 | — |
| BICX | BioCorRx Inc. | $6.22M | $0.21 | — |
News headlines (Yahoo Finance, 1h cache)
Advanced Biomed Inc. Announces 1 for 20 Share Consolidation
2026-02-18 12:00 · Yahoo
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
2026-02-13 13:00 · Yahoo
Advanced Biomed sells Hong Kong subsidiary for $23,000
2025-12-31 15:25 · Yahoo
Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary
2025-12-30 15:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.